Azathioprine or 6-mercaptopurine for maintenance of remission in Crohn's disease (Q24241006)

https://api.crossref.org/works/10.1002%2F14651858.CD000067.PUB2

7 January 2021

Thiopurine drug adverse effects in a population of New Zealand patients with inflammatory bowel disease.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000067.PUB2

7 January 2021

A controlled trial of azathioprine in Crohn's disease

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000067.PUB2

7 January 2021

Azathioprine and 6-mercaptopurine have a role in the treatment of Crohn's disease

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000067.PUB2

7 January 2021

Azathioprine has a very limited role in the treatment of Crohn's disease

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000067.PUB2

7 January 2021

A method for assessing the quality of a randomized control trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000067.PUB2

7 January 2021

The long-term efficacy of azathioprine does not wane after four years of continuous treatment in patients with steroid-dependent luminal Crohn's disease

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000067.PUB2

7 January 2021

Azathioprine in Crohn's disease

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000067.PUB2

7 January 2021

Controlled trial of azathioprine in Crohn's disease

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000067.PUB2

7 January 2021

Double-blind withdrawal trial of azathioprine as maintenance treatment for Crohn's disease

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000067.PUB2

7 January 2021

Long-term follow-up of patients with Crohn's disease treated with azathioprine or 6-mercaptopurine.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000067.PUB2

7 January 2021

Azathioprine, 6-mercaptopurine in inflammatory bowel disease: pharmacology, efficacy, and safety

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000067.PUB2

7 January 2021

Postoperative maintenance of Crohn's disease remission with 6-mercaptopurine, mesalamine, or placebo: a 2-year trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000067.PUB2

7 January 2021

Azathioprine and mesalamine for prevention of relapse after conservative surgery for Crohn's disease.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000067.PUB2

7 January 2021

A randomized, double-blind, controlled withdrawal trial in Crohn's disease patients in long-term remission on azathioprine

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000067.PUB2

7 January 2021

Azathioprine as a postoperative prophylaxis reduces symptoms in aggressive Crohn's disease

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000067.PUB2

7 January 2021

6-mercaptopurine or methotrexate added to prednisone induces and maintains remission in steroid-dependent inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000067.PUB2

7 January 2021

Randomized controlled azathioprine withdrawal after more than two years treatment in Crohn's disease: increased relapse rate the following year

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000067.PUB2

7 January 2021

Azathioprine and 6-mercaptopurine pharmacogenetics and metabolite monitoring in inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000067.PUB2

7 January 2021

Long-term results with azathioprine therapy in patients with corticosteroid-dependent Crohn's disease: open-label prospective study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000067.PUB2

7 January 2021

Increased risk of lymphoma among inflammatory bowel disease patients treated with azathioprine and 6-mercaptopurine

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000067.PUB2

7 January 2021

A controlled double blind study of azathioprine in the management of Crohn's disease

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000067.PUB2

7 January 2021

The efficacy of azathioprine for the treatment of inflammatory bowel disease: a 30 year review

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000067.PUB2

7 January 2021

Azathioprine and 6-mercaptopurine in Crohn disease. A meta-analysis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000067.PUB2

7 January 2021

10.1002/14651858.CD000067.PUB2

Identifiers

DOI

1 reference

Consolidated OpenCitations Corpus – April 2017

1 reference

Consolidated OpenCitations Corpus – April 2017

PubMed publication ID

19160175

1 reference

Consolidated OpenCitations Corpus – April 2017